Co-diagnostics, inc. to introduce at home/point of care device at aacc on sept 28

Salt lake city, sept. 27, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be introducing its upcoming at-home and point-of-care pcr device in a press conference at the 2021 aacc annual scientific meeting & clinical lab expo, held september 26-30 in atlanta, ga, as well as hosting a booth to promote its existing suite of diagnostics products and technology applications.
CODX Ratings Summary
CODX Quant Ranking